Tech Company Financing Transactions
Vitestro Funding Round
Vitestro secured a $70 million Series B financing round on 3/10/2026. Investors included European Innovation Council Fund, InterVest and Invest-NL.
Transaction Overview
Company Name
Announced On
3/10/2026
Transaction Type
Venture Equity
Amount
$70,000,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds to further advance the platform's technical capabilities and integration into existing technology infrastructure, conduct essential clinical studies and pilot programs to embed the technology into real-world workflows, and expand its team to meet growing demand from healthcare providers.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
Europalaan 500 1.N.2
Utrecht, 3526 KS
The Netherlands
Utrecht, 3526 KS
The Netherlands
Phone
Website
Email Address
Overview
Vitestro will be the first to bring an autonomous blood drawing experience to European hospitals. Blood drawing, performed billions of times per year worldwide, is key to clinical diagnosis. Given the mounting shortages of healthcare personnel, there is a clear need for a future-proof system to automate the workflow and guarantee continuity of care.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Toon Overbeeke
Co-Founder
Brian Joseph
Browse more venture capital transactions:
Prev: 3/10/2026: Seprify venture capital transaction
Next: 3/10/2026: Outpost venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on all VC transactions involving tech companies. VC transactions on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs